Sophion Therapeutics entered the industry of Commercial Medical Research in 2007 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Salvatore Forenza by calling (203) 497-8500 during business hours. You can also write to the business’ Single Location at 300 George St, New Haven, Connecticut CT 06511. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Sophion Therapeutics |
| Representative: | Salvatore Forenza |
| Place of Business: | 300 George St, New Haven, CT 06511 |
| Contact Number: | (203) 497-8500 |
| Type of Service: | Commercial Medical Research |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2007 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Sophion Therapeutics is a company operating from New Haven, Connecticut providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2007 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Sophion Therapeutics has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Salvatore Forenza at (203) 497-8500 for related queries, or to locate its Single Location using the coordinates 41.305856,-72.932609.
The Single Location can also be found at the street address 300 George St in New Haven, Connecticut 06511 and can be engaged online through the company website at , the company Twitter , and Facebook page .